Cargando…
Collagen type XV and the ‘osteogenic status’
We have previously demonstrated that collagen type XV (ColXV) is a novel bone extracellular matrix (ECM) protein. It is well known that the complex mixture of multiple components present in ECM can help both to maintain stemness or to promote differentiation of stromal cells following change in qual...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571525/ https://www.ncbi.nlm.nih.gov/pubmed/28332281 http://dx.doi.org/10.1111/jcmm.13137 |
_version_ | 1783259357685743616 |
---|---|
author | Lisignoli, Gina Lambertini, Elisabetta Manferdini, Cristina Gabusi, Elena Penolazzi, Letizia Paolella, Francesca Angelozzi, Marco Casagranda, Veronica Piva, Roberta |
author_facet | Lisignoli, Gina Lambertini, Elisabetta Manferdini, Cristina Gabusi, Elena Penolazzi, Letizia Paolella, Francesca Angelozzi, Marco Casagranda, Veronica Piva, Roberta |
author_sort | Lisignoli, Gina |
collection | PubMed |
description | We have previously demonstrated that collagen type XV (ColXV) is a novel bone extracellular matrix (ECM) protein. It is well known that the complex mixture of multiple components present in ECM can help both to maintain stemness or to promote differentiation of stromal cells following change in qualitative characteristics or concentrations. We investigated the possible correlation between ColXV expression and mineral matrix deposition by human mesenchymal stromal cells (hMSCs) with different osteogenic potential and by osteoblasts (hOBs) that are able to grow in culture medium with or without calcium. Analysing the osteogenic process, we have shown that ColXV basal levels are lower in cells less prone to osteo‐induction such as hMSCs from Wharton Jelly (hWJMSCs), compared to hMSCs that are prone to osteo‐induction such as those from the bone marrow (hBMMSCs). In the group of samples identified as ‘mineralized MSCs’, during successful osteogenic induction, ColXV protein continued to be detected at substantial levels until early stage of differentiation, but it significantly decreased and then disappeared at the end of culture when the matrix formed was completely calcified. The possibility to grow hOBs in culture medium without calcium corroborated the results obtained with hMSCs demonstrating that calcium deposits organized in a calcified matrix, and not calcium ‘per se’, negatively affected ColXV expression. As a whole, our data suggest that ColXV may participate in ECM organization in the early‐phases of the osteogenic process and that this is a prerequisite to promote the subsequent deposition of mineral matrix. |
format | Online Article Text |
id | pubmed-5571525 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-55715252017-09-01 Collagen type XV and the ‘osteogenic status’ Lisignoli, Gina Lambertini, Elisabetta Manferdini, Cristina Gabusi, Elena Penolazzi, Letizia Paolella, Francesca Angelozzi, Marco Casagranda, Veronica Piva, Roberta J Cell Mol Med Short Communication We have previously demonstrated that collagen type XV (ColXV) is a novel bone extracellular matrix (ECM) protein. It is well known that the complex mixture of multiple components present in ECM can help both to maintain stemness or to promote differentiation of stromal cells following change in qualitative characteristics or concentrations. We investigated the possible correlation between ColXV expression and mineral matrix deposition by human mesenchymal stromal cells (hMSCs) with different osteogenic potential and by osteoblasts (hOBs) that are able to grow in culture medium with or without calcium. Analysing the osteogenic process, we have shown that ColXV basal levels are lower in cells less prone to osteo‐induction such as hMSCs from Wharton Jelly (hWJMSCs), compared to hMSCs that are prone to osteo‐induction such as those from the bone marrow (hBMMSCs). In the group of samples identified as ‘mineralized MSCs’, during successful osteogenic induction, ColXV protein continued to be detected at substantial levels until early stage of differentiation, but it significantly decreased and then disappeared at the end of culture when the matrix formed was completely calcified. The possibility to grow hOBs in culture medium without calcium corroborated the results obtained with hMSCs demonstrating that calcium deposits organized in a calcified matrix, and not calcium ‘per se’, negatively affected ColXV expression. As a whole, our data suggest that ColXV may participate in ECM organization in the early‐phases of the osteogenic process and that this is a prerequisite to promote the subsequent deposition of mineral matrix. John Wiley and Sons Inc. 2017-03-22 2017-09 /pmc/articles/PMC5571525/ /pubmed/28332281 http://dx.doi.org/10.1111/jcmm.13137 Text en © 2017 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Communication Lisignoli, Gina Lambertini, Elisabetta Manferdini, Cristina Gabusi, Elena Penolazzi, Letizia Paolella, Francesca Angelozzi, Marco Casagranda, Veronica Piva, Roberta Collagen type XV and the ‘osteogenic status’ |
title | Collagen type XV and the ‘osteogenic status’ |
title_full | Collagen type XV and the ‘osteogenic status’ |
title_fullStr | Collagen type XV and the ‘osteogenic status’ |
title_full_unstemmed | Collagen type XV and the ‘osteogenic status’ |
title_short | Collagen type XV and the ‘osteogenic status’ |
title_sort | collagen type xv and the ‘osteogenic status’ |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571525/ https://www.ncbi.nlm.nih.gov/pubmed/28332281 http://dx.doi.org/10.1111/jcmm.13137 |
work_keys_str_mv | AT lisignoligina collagentypexvandtheosteogenicstatus AT lambertinielisabetta collagentypexvandtheosteogenicstatus AT manferdinicristina collagentypexvandtheosteogenicstatus AT gabusielena collagentypexvandtheosteogenicstatus AT penolazziletizia collagentypexvandtheosteogenicstatus AT paolellafrancesca collagentypexvandtheosteogenicstatus AT angelozzimarco collagentypexvandtheosteogenicstatus AT casagrandaveronica collagentypexvandtheosteogenicstatus AT pivaroberta collagentypexvandtheosteogenicstatus |